Aardark Therapeutics
PublicAardark Therapeutics is now publicly traded
The data on this page reflects Aardark Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Series C
May 9, 2024
Total Funding Raised
$129M
Company Overview
Aardark Therapeutics operates in Biotech and is based in San Diego, California. It has raised $129M.
Aardvark Therapeutics is a biopharmaceutical company specializing in small molecule therapeutics aimed at treating obesity and rare genetic metabolic diseases.
Sector
Biotech
AI Layer
Non-AI
Aardark Therapeutics Comparables
Compare Aardark Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kallyope | 79% | |
| ConSynance Therapeutics | 76% | |
| Aphaia Pharma | 65% |
For institutional investors. Book with your work email.
Aardark Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 9, 2024 | ||||
| Series B | Aug 5, 2021 | ||||
| Series A | Nov 29, 2019 |
For institutional investors. Book with your work email.
Aardark Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BNH INVESTMENT | Series B, Series A |
| SymBiosis Capital Management | Series C |
| Foundation for Prader-Willi Research | Series C, Series B |
| Premier Partners | Series B, Series A |
| LG Technology Ventures | Series C |
| Cormorant Capital | Series C |
| Cantor Ventures | Series C |
For institutional investors. Book with your work email.
Aardark Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.